S. Brunet

J. Briones, J. Delgado, J. Sierra, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning.

J. Briones, J. Queraltó, J. Sierra, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous stem cell transplantation for high-risk Hodgkin's disease: improvement over time and impact of conditioning regimen.

J. Sierra, S. Brunet, R. Martino, 2000, Haematologica.

Acute Leukemias Interferon α plus intermittent oral AraC ocfosfate ( YNK-01 ) in chronic myeloid leukemia primarily resistant or with minimal cytogenetic response to interferon

S. Brunet, R. Martino, F. Cervantes, 2001 .

Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study

Marcos González, A. Oriol, M. Sanz, 2015, Haematologica.

p53 mutation in a case of blastic transformation of follicular lymphoma with double bcl-2 rearrangement (MBR and VCR).

G. Gaidano, M. Baiget, G. Saglio, 1998, Leukemia & lymphoma.

Allogeneic stem cell transplantation for advanced low-grade lymphoproliferative disorders: report of six cases.

S. Brunet, R. Martino, C. Martínez, 1996, Haematologica.

Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy

J. Hernández-Rivas, S. Brunet, J. Ribera, 2016, Leukemia & lymphoma.

WT1 monitoring in core binding factor AML: comparison with specific chimeric products.

A. Aventín, J. Sierra, A. Lasa, 2009, Leukemia research.

Hematological recovery after autologous bone marrow transplantation in acute leukemia: predictive factors.

A. Grañena, A. Domingo, S. Brunet, 1993, Journal of hematotherapy.

PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation

Marcos González, I. Buño, C. Solano, 2018, Annals of Hematology.

Donor CTLA-4 Genotype Modulates the Immune Response to Minor Histocompatibility Antigen Mismatches.

Marcos González, I. Buño, S. Brunet, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors.

I. Buño, C. Solano, E. Tuset, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy

J. Esteve, M. Tormo, J. Besalduch, 2009, Leukemia.

Uniparental disomy may be associated with microsatellite instability in acute myeloid leukemia (AML) with a normal karyotype

A. Aventín, J. Sierra, Elena Serrano, 2008, Leukemia and Lymphoma.

Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation.

E. Kimby, E. Montserrat, W. Siegert, 2003, Haematologica.

Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications

A. Grañena, S. Sanjosé, S. Brunet, 1997, Bone Marrow Transplantation.

Therapy of paraneoplastic pemphigus with Rituximab: a case report and review of literature

S. Brunet, E. Roé, A. Francia, 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms.

M. C. Aguilera-Morillo, J. Romo, R. Lillo, 2018, Blood advances.

Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation.

J. Miguel, S. Brunet, J. Pérez-Simón, 2003, Blood.

MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings

F. Fernández‐Avilés, S. Brunet, R. Martino, 2010, Bone Marrow Transplantation.

The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation

Marcos González, I. Buño, C. Solano, 2015, PLoS ONE.

A polymorphism in the TYMP gene is associated with the outcome of HLA‐identical sibling allogeneic stem cell transplantation

I. Buño, C. Solano, S. Brunet, 2013, American journal of hematology.

Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: a single-center experience

S. Brunet, R. Martino, R. Manteiga, 1998, Bone Marrow Transplantation.

Tuberculosis in bone marrow transplant recipients: report of two cases and review of the literature.

S. Brunet, R. Martino, C. Martínez, 1996, Bone marrow transplantation.

Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor.

S. Brunet, R. Martino, J. García, 1998, Haematologica.

Autologous stem cell transplantation for poor prognosis Hodgkin’s disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative group

J. Garcia-conde, J. Maldonado, S. Brunet, 1997, Bone Marrow Transplantation.

High-dose chemotherapy with bone marrow rescue for treatment of Hodgkin's disease.

S. Brunet, A. Sureda, P. Madoz, 1992, Leukemia & lymphoma.

and idarubicin with acute promyelocytic leukemia treated with all-trans retinoic acid Causes and prognostic factors of remission induction failure in patients

Marcos González, E. Vellenga, M. Sanz, 2013 .

Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT

J. Briones, J. Delgado, S. Brunet, 2009, Bone Marrow Transplantation.

Isolation of CD34+ progenitor cells from peripheral blood by use of an automated immunomagnetic selection system: factors affecting the results

A. Grañena, M. Picón, S. Brunet, 2000, Transfusion.

Clinical outcome after sex-mismatched allogeneic stem cell transplantation from human lymphocyte antigen-identical sibling donors: influence of stem cell source

S. Brunet, J. Ribera, A. Jiménez-Velasco, 2006, Leukemia.

Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma

G. Perea, S. Brunet, R. Martino, 2001, Annals of Hematology.

CD34+-enriched-CD19+-depleted autologous peripheral blood stem cell transplantation for chronic lymphoproliferative disorders: high purging efficiency but increased risk of severe infections.

J. Briones, J. Esteve, E. Montserrat, 2002, Experimental hematology.

Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation

C. Solano, S. Brunet, R. Martino, 2001, Bone Marrow Transplantation.

Oral induction and consolidation chemotherapy with idarubicin and etoposide in elderly patients with acute myeloid leukemia.

J. Esteve, A. Oriol, S. Brunet, 2003, Haematologica.

Allogeneic transplantation of CD34+-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation

E. Montserrat, J. Garcia-conde, C. Solano, 2001, Bone Marrow Transplantation.

Feasibility and efficacy of outpatient therapy with intermediate dose cytarabine, fludarabine and idarubicin for patients with acute myeloid leukaemia aged 70 or older

A. Oriol, S. Brunet, J. Ribera, 2015, European journal of haematology.

J. Esteve, M. Tormo, J. Sierra, 2022, Bone Marrow Transplantation.

Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes.

J. Sierra, C. Solano, J. S. San Miguel, 2002, Blood.

Short communication Typical CBF b /MYH11 fusion due to insertion of the 3 9 - MYH11 gene into 16q22 in acute monocytic leukemia with normal chromosomes 16 and trisomies 8 and 22

A. Aventín, J. Sierra, C. Mecucci, 2000 .

Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival

J. Esteve, L. Escoda, M. Tormo, 2018, Leukemia & lymphoma.

Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1

J. Esteve, L. Arenillas, M. Rozman, 2014, Annals of Hematology.

Multivariate Analysis of the Impact of Pre-Treatment Serum Ferritin Level On Response and Overall Survival in Patients with Myelodysplastic Syndromes Treated with Azacitidine

M. Tormo, S. Brunet, J. Bargay, 2012 .

MUTATIONAL ANALYSIS OF p 53 IN 16 CASES OF ACUTE LYMPHOBLASTIC LEUKEMIA AND BURKITT ’ S LYMPHOMA

M. Baiget, A. Lasa, S. Brunet, 2005 .

Salvage chemotherapy with IAPVP-16 for advanced refractory or relapsed follicular lymphomas.

S. Brunet, R. Martino, A. Sureda, 1999, Haematologica.

Treatment of young patients with Philadelphia chromosome‐positive acute lymphoblastic leukaemia using increased dose of imatinib and deintensified chemotherapy before allogeneic stem cell transplantation

J. Hernández-Rivas, M. Barrios, S. Brunet, 2012, British journal of haematology.

Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML

J. Esteve, M. Tormo, S. Brunet, 2013, Leukemia.

Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disorders

J. Briones, A. Salar, G. Perea, 2000, Bone Marrow Transplantation.

Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique

J. Garcia-conde, C. Solano, S. Brunet, 1998, Bone Marrow Transplantation.

Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantation.

J. Briones, L. Villela, J. Sierra, 2003, Haematologica.

Extrapulmonary tuberculosis and non-Hodgkin's lymphoma: coexistence in an abdominal lymph node.

S. Brunet, R. Martino, C. Martínez, 1995, Haematologica.

FLT3 mutations are associated with other molecular lesions in AML.

A. Aventín, J. Sierra, A. Lasa, 2004, Leukemia research.

Early clinical impact of iron overload in stem cell transplantation. A prospective study

J. Briones, J. Sierra, M. Baiget, 2007, Annals of Hematology.

Allogeneic or autologous stem cell transplantation following salvage chemotherapy for adults with refractory or relapsed acute lymphoblastic leukemia

S. Brunet, R. Martino, A. Sureda, 1998, Bone Marrow Transplantation.

Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk‐adapted protocols

M. Tormo, J. Hernández-Rivas, J. Cervera, 2014, Cancer.

Validation of Comorbidity Indexes in Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation. the Hematopoietic Cell Transplantation Comorbidity Index Is the Best Predictor of NRM and Survival.

J. Briones, J. Delgado, J. Sierra, 2008 .

Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study

C. Solano, S. Brunet, J. Ribera, 2009, Haematologica.

Autologous stem cell transplantation in advanced follicular lymphoma. A single center experience.

J. Briones, S. Brunet, R. Martino, 1999, Haematologica.

Autologous or allogeneic stem cell transplantation in advanced low-grade lymphomas?

J. Sierra, S. Brunet, R. Martino, 1998, Blood.

Patients with biochemical iron overload: causes and characteristics of a cohort of 150 cases

J. Briones, M. Baiget, S. Brunet, 2003, Annals of Hematology.

Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation.

C. Solano, M. Sanz, S. Brunet, 2003, Experimental hematology.

Successful treatment of chronic autoimmune neutropenia with cyclosporin A.

S. Brunet, R. Martino, E. Muñiz‐Díaz, 1994, Haematologica.

Successful treatment of pneumonia due to Scedosporium apiospermum with itraconazole: case report.

S. Brunet, R. Martino, V. Ausina, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Identification of Poor Risk Patients in Low and Intermediate-1 (Int-1) IPSS MDS with the New Ipssr Index and Comparison with Other Prognostic Indexes. A Study by the Spanish Group of MDS (GESMD)

M. Tormo, S. Brunet, J. Bargay, 2012 .

Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease.

J. Sierra, S. Brunet, J. Pérez-Simón, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry

C. Solano, S. Brunet, F. Hernández-Navarro, 1998, Bone Marrow Transplantation.

Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis.

J. Esteve, J. Sierra, M. Labopin, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

UGT2B17 minor histocompatibility mismatch and clinical outcome after HLA-identical sibling donor stem cell transplantation

I. Buño, S. Brunet, C. Martínez, 2016, Bone Marrow Transplantation.

Degree of mucositis and duration of neutropenia are the major risk factors for early post‐transplant febrile neutropenia and severe bacterial infections after reduced‐intensity conditioning

J. Briones, J. Delgado, J. Sierra, 2012, European journal of haematology.

Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols

M. Tormo, J. Cervera, S. Brunet, 2017, Leukemia & lymphoma.

Loss of heterozygosity of the polymorphic PIG3 microsatellite with low frequency in de novo acute myeloid leukemias

A. Lasa, G. Perea, S. Brunet, 2004, Leukemia.

Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors

A. Verdeguer, M. Sanz, S. Brunet, 2002, Transfusion.

Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation.

A. Verdeguer, M. Sanz, S. Brunet, 2003, Haematologica.

A. Verdeguer, M. Sanz, S. Brunet, 2001, Transfusion.

High-Dose Chemotherapy with Bone Rescue for Treatment of Hodgkin's Marrow Disease

J. Mate, S. Brunet, A. Sureda, 1992 .

ADMINISTRATION OF rHuG–CSF TO YOUNG DONORS

A. Verdeguer, M. Sanz, S. Brunet, 2002 .

Comparison Between Lymphoglobuline- and Thymoglobuline-Based Immunosuppressive Therapy as First-Line Treatment for Patients with Aplastic Anemia.

E. Colado, A. Rosell, S. Brunet, 2009 .

Absence of veno‐occlussive disease in a cohort of multiple myeloma patients undergoing autologous stem cell transplantation with targeted busulfan dosage

J. Queraltó, R. Farré, S. Brunet, 2006, European journal of haematology.

Disparity for the minor histocompatibility antigen HA‐1 is associated with an increased risk of acute graft‐versus‐host disease (GvHD) but it does not affect chronic GvHD incidence, disease‐free survival or overall survival after allogeneic human leucocyte antigen‐identical sibling donor transplanta

A. Grañena, J. Sierra, C. Solano, 2001, British journal of haematology.

Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment.

R. Miralbell, M. Ozsahin, I. Carrió, 2004, International journal of radiation oncology, biology, physics.

The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings.

E. Montserrat, J. Garcia-conde, C. Solano, 2001, Blood.

Bone Marrow WT1 Levels in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplasia: Clinically Relevant Time Points and 100 Copies Threshold Value.

J. Sierra, S. Brunet, J. Nomdedéu, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic growth factor (G-CSF or GM-CSF) after salvage chemotherapy in refractory or relapsed adult de novo acute leukemia.

S. Brunet, R. Martino, A. Sureda, 1996, Leukemia & lymphoma.

Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to Therapy

J. Briones, J. Sierra, S. Brunet, 2018, Clinical lymphoma, myeloma & leukemia.

Allogeneic peripheral blood stem cell transplantation with CD34+-cell selection and delayed T-cell add-back in adults. Results of a single center pilot study.

S. Brunet, R. Martino, A. Sureda, 2000, Haematologica.

Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients

C. Solano, S. Brunet, R. Martino, 2002, British journal of haematology.

International and Italian prognostic indices in follicular lymphoma.

J. Briones, A. López-Guillermo, S. Montoto, 2003, Haematologica.

Effect of Discontinuing Prophylaxis with Norfloxacin in Patients with Hematologic Malignancies and Severe Neutropenia

S. Brunet, R. Martino, A. Sureda, 1998, Acta Haematologica.

Conventional versus reduced‐intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies

J. Briones, M. Sanz, S. Brunet, 2005, European journal of haematology.

Reduced transfusion requirements in a splenectomized patient undergoing bone marrow transplantation.

S. Brunet, R. Martino, E. Muñiz‐Díaz, 1994, Acta haematologica.

Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA group.

L. Escoda, M. Tormo, A. Cladera, 2016, Leukemia research.

Incorporating posttransplant cyclophosphamide-based prophylaxis as standard-of-care outside the haploidentical setting: challenges and review of the literature

J. Briones, J. Sierra, S. Brunet, 2019, Bone Marrow Transplantation.

Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients

F. Fernández‐Avilés, J. S. San Miguel, S. Brunet, 2006, Leukemia.

Strategies to reduce transplant-related mortality after allogeneic stem cell transplantation in elderly patients: Comparison of reduced-intensity conditioning and unmanipulated peripheral blood stem cells vs a myeloablative regimen and CD34+ cell selection.

J. Briones, J. Sierra, S. Brunet, 2003, Experimental hematology.

Evaluation of the outcomes of newly diagnosed patients with high-risk myelodysplastic syndrome according to the initial therapeutical strategies chosen in usual clinical practice

M. Tormo, S. Brunet, J. Bargay, 2022, Leukemia & lymphoma.

Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols

J. Esteve, M. Tormo, J. Sierra, 2020, European journal of haematology.

Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy.

J. Esteve, L. Escoda, M. Tormo, 2013, Blood.

Hematopoietic transplantation for acute myeloid leukemia with internal tandem duplication of FLT3 gene (FLT3/ITD)

J. Sierra, S. Brunet, R. Martino, 2013, Current opinion in oncology.

Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease

J. Esteve, M. Tormo, D. Colomer, 2020, British journal of haematology.

Application of a digital PCR method for WT1 to myeloid neoplasms in CR and deep ELN WT1 molecular response (< 10 copies)

J. Esteve, M. Tormo, S. Brunet, 2020, Annals of Hematology.

Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.

S. Brunet, R. Martino, A. Sureda, 1997, Haematologica.

R. Salazar, S. Brunet, R. Martino, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Severe infections after allogeneic peripheral blood stem cell transplantation: a matched-pair comparison of unmanipulated and CD34+ cell-selected transplantation.

C. Solano, S. Brunet, R. Martino, 2001, Haematologica.

Prevention of invasive fungal infections during bone marrow transplantation

S. Brunet, R. Martino, A. Sureda, 1994, Annals of Hematology.

Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases.

S. Brunet, J. Nomdedéu, R. Martino, 1994, Bone marrow transplantation.

Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia

F. Prósper, J. Hernández-Rivas, J. Sierra, 2011, Haematologica.

Downregulation of EVI 1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia

F. Prósper, J. Hernández-Rivas, J. Sierra, 2011 .

Low Rate of Invasive Fungal Infections During Induction and Consolidation Chemotherapy for Adults with De Novo Acute Myeloid Leukemia Without Anti-mold Prophylaxis: Single-Center 2002–2018 Empirical/Pre-emptive Approach

J. Briones, J. Sierra, S. Brunet, 2020, Mycopathologia.

Final Results of the AML12 Trial of the Spanish Cetlam Group in Adults with Acute Myeloid Leukemia (AML) up to the Age of 70 Years: Risk Adapted Post-Remission Allocation Based on Genetic Data and Minimal Residual Disease

J. Esteve, L. Escoda, M. Tormo, 2019, Blood.

A scoring system to predict the risk of death during induction with anthracycline plus cytarabine‐based chemotherapy in patients with de novo acute myeloid leukemia

J. Esteve, M. Tormo, M. Sanz, 2012, Cancer.

Reduction of infection-related mortality after allogeneic PBSCT from HLA-identical siblings: longitudinal analysis from 1994 to 2008 at a single institution

J. Briones, J. Delgado, S. Brunet, 2011, Bone Marrow Transplantation.

Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.

J. Esteve, M. Tormo, Marcos González, 2009, Blood.

Viridans streptococcal shock syndrome during bone marrow transplantation.

S. Brunet, R. Martino, R. Manteiga, 1995, Acta haematologica.

Achromobacter xylosoxidans bacteremia in patients with hematologic malignancies.

S. Brunet, R. Martino, A. Sureda, 1998, Haematologica.

Bacteremia due to glucose non-fermenting gram-negative bacilli in patients with hematological neoplasias and solid tumors

R. Salazar, S. Brunet, R. Martino, 1996, European Journal of Clinical Microbiology and Infectious Diseases.

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome.

M. Sanz, G. Ossenkoppele, S. Brunet, 2010, Blood.

Bone marrow WT1 levels in patients with myeloid neoplasms treated with 5‐azacytidine: Identification of responding patients

J. Sierra, S. Brunet, J. Nomdedéu, 2019, European journal of haematology.

Beta2‐microglobulin is a better predictor of treatment‐free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate

Julio Delgado, Guy Pratt, J. Briones, 2009, British journal of haematology.

Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen.

J. Briones, J. Delgado, S. Brunet, 2007, Cytotherapy.

Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission

S. Brunet, R. Martino, J. Sierra, 2008, Bone Marrow Transplantation.

Treatment of refractory and relapsed adult acute leukemia using a uniform chemotherapy protocol.

S. Brunet, R. Martino, A. Sureda, 1993, Leukemia & lymphoma.

Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study.

J. Esteve, A. Oriol, S. Brunet, 2005, Haematologica.

Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial

J. Esteve, M. Tormo, Marcos González, 2010, Haematologica.

M. Sanz, G. Ossenkoppele, S. Brunet, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature

Jordi Esteve, David Gallardo, J. Esteve, 2015, Oncotarget.

A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia

J. Esteve, J. Sierra, S. Kalko, 2018, Leukemia & lymphoma.

Acute tumor lysis syndrome complicating conditioning therapy for bone marrow transplantation in a patient with chronic lymphocytic leukemia.

S. Brunet, R. Martino, A. Sureda, 1994, Bone marrow transplantation.

Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study.

J. Esteve, A. Oriol, M. Sanz, 2003, Haematologica.

Genetic diagnosis by comparative genomic hybridization in adult de novo acute myelocytic leukemia.

F. Solé, A. Carrió, S. Casas, 2004, Cancer genetics and cytogenetics.

Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma

J. Briones, J. Sierra, J. Prat, 2006, Annals of Hematology.

Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial.

J. Esteve, L. Escoda, M. Tormo, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens.

J. Esteve, L. Escoda, M. Tormo, 2011, Blood.

Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies.

A. Aventín, J. Sierra, M. Carnicer, 2001, Haematologica.

Intensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia: results of a prospective trial.

A. Aventín, S. Brunet, J. Nomdedéu, 1999, Haematologica.

Mutational analysis of p53 in 16 cases of acute lymphoblastic leukemia and Burkitt's lymphoma.

M. Baiget, A. Lasa, S. Brunet, 1997, Haematologica.

Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.

A. Aventín, J. Sierra, Elena Serrano, 2008, Leukemia research.

Profile of polymorphisms of drug‐metabolising enzymes and the risk of therapy‐related leukaemia

M. Tormo, D. Colomer, Marcos González, 2007, British journal of haematology.

Pulmonary enterovirus infections in stem cell transplant recipients

S. Brunet, R. Martino, I. Badell, 1999, Bone Marrow Transplantation.

Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish Group.

I. Benet, J. Garcia-conde, C. Solano, 1996, Bone marrow transplantation.

Characteristics and outcome of adult patients with acute promyelocytic leukemia and increased body mass index treated with the PETHEMA Protocols

J. Esteve, M. Tormo, Marcos González, 2019, European journal of haematology.

Real life outcomes of patients aged ≥75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry

J. Esteve, L. Escoda, M. Sanz, 2019, Leukemia & lymphoma.

Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy

J. Esteve, M. Tormo, E. Vellenga, 2018, Leukemia & lymphoma.

Multivariate time‐dependent comparison of the impact of lenalidomide in lower‐risk myelodysplastic syndromes with chromosome 5q deletion

M. Tormo, S. Brunet, J. Bargay, 2014, British Journal of Haematology.

Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

M. Tormo, Marcos González, J. Hernández-Rivas, 2010, Haematologica.

Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group.

J. Esteve, D. Colomer, Marcos González, 2008, Blood.

Feasibility and results of autologous stem cell transplantation in de novo acute myeloid leukemia in patients over 60 years old. Results of the CETLAM AML-99 protocol.

J. Esteve, E. Montserrat, M. Tormo, 2004, Haematologica.

Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement

A. Grañena, X. Castellsagué, M. Picón, 1999, Bone Marrow Transplantation.

Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia.

S. Brunet, J. Nomdedéu, R. Martino, 2000, Haematologica.

When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine)

J. Briones, J. Sierra, S. Brunet, 2019, Annals of Hematology.

Immunomagnetic bone marrow (BM) and peripheral blood progenitor cell (PBPC) purging in follicular lymphoma (FL)

E. González-Barca, A. Grañena, M. Picón, 1999, Bone Marrow Transplantation.

Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin

S. Brunet, R. Martino, A. Santamaría, 1997, Bone Marrow Transplantation.

Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yields.

A. Verdeguer, M. Sanz, S. Brunet, 2002, Journal of hematotherapy & stem cell research.

Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings.

E. Montserrat, J. Garcia-conde, C. Solano, 2002, Blood.

Single-agent GvHD prophylaxis with tacrolimus after post-transplant high-dose cyclophosphamide is a valid option for haploidentical transplantation in adults with hematological malignancies

S. Brunet, R. Martino, C. Ferrá, 2017, Bone Marrow Transplantation.

Second bone marrow transplantation for leukemia in untreated relapse.

M. Baiget, S. Brunet, R. Martino, 1994, Bone marrow transplantation.

Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease

J. Briones, S. Brunet, R. Martino, 2017, Bone Marrow Transplantation.

CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation

J. Maldonado, S. Brunet, J. Bueno, 2002, Bone Marrow Transplantation.

Various patterns of chimerism after allogeneic bone marrow transplantation for advanced chronic lymphocytic leukemia.

M. Baiget, S. Brunet, R. Martino, 1995, Bone marrow transplantation.

Efficient peripheral blood stem cell mobilization with low-dose G-CSF (50 μ g/m2) after salvage chemotherapy for lymphoma

S. Brunet, R. Martino, J. García, 1997, Bone Marrow Transplantation.

Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience.

J. Briones, J. Delgado, J. Sierra, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA-DPB1 MISMATCH IN HLA-A-B-DRB1 IDENTICAL SIBLING DONOR STEM CELL TRANSPLANTATION AND ACUTE GRAFT-VERSUS-HOST DISEASE

Marcos González, J. Sierra, J. Román, 2004, Transplantation.

Favourable effect of the combination of acute and chronic graft‐versus‐host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies

J. Sierra, C. Solano, J. Maldonado, 2001, British journal of haematology.

High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation. The Spanish Group of Allo-PBPCT.

J. Garcia-conde, C. Solano, S. Brunet, 1997, Haematologica.

Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft‐versus‐host disease after allogeneic transplantation

J. S. San Miguel, M. D. del Cañizo, S. Brunet, 2005, British journal of haematology.

Allogeneic Bone Marrow Transplantation in Chronic Lymphocytic Leukemia: 17 Cases. Report of the EBMT.

A. Gratwohl, A. Moine, S. Brunet, 1991, Leukemia & lymphoma.

Frozen vs. nonfrozen bone marrow for autologous transplantation in lymphomas: A report from the Spanish GEL/TAMO Cooperative Group

E. Montserrat, J. Garcia-conde, C. Solano, 1993, Annals of Hematology.

Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study

J. Garcia-conde, C. Solano, S. Brunet, 1998, Bone Marrow Transplantation.

Allogeneic stem cell transplantation with reduced-intensity conditioning is potentially feasible as an outpatient procedure

S. Brunet, R. Martino, A. Sureda, 2003, Bone Marrow Transplantation.

Peripheral blood stem cell mobilization in refractory autoimmune Evans syndrome: a cautionary case report

S. Brunet, R. Martino, A. Sureda, 1997, Bone Marrow Transplantation.

[DNA polymorphisms as implant markers in allogeneic bone marrow transplantation. Preliminary evaluation].

T. Casals, M. Baiget, S. Brunet, 1989, Medicina clinica.

Long-term outcome of allogeneic PBSC transplantation in pediatric patients with hematological malignancies: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON) and the Spanish Group for Allogeneic Peripheral Blood Transplantation (GETH)

A. Verdeguer, S. Brunet, J. Díez, 2005, Bone Marrow Transplantation.

Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry

C. Solano, A. Verdeguer, S. Brunet, 1999, Bone Marrow Transplantation.

Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase

A. Grañena, M. Picón, S. Brunet, 1997, Bone Marrow Transplantation.

VARIANT t(2;18) TRANSLOCATION IN A BURKITT CONVERSION OF FOLLICULAR LYMPHOMA

A. Aventín, C. Mecucci, S. Brunet, 1990, British journal of haematology.

Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual disease

J. Esteve, L. Escoda, M. Tormo, 2013, European journal of haematology.

Comparison of the classic Glucksberg criteria and the IBMTR Severity Index for grading acute graft-versus-host disease following HLA-identical sibling stem cell transplantation

S. Brunet, R. Martino, I. Badell, 1999, Bone Marrow Transplantation.

Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients

J. Esteve, L. Escoda, J. van Lunzen, 2014, Leukemia & lymphoma.

Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab

J. Briones, S. Brunet, R. Martino, 2015, Bone Marrow Transplantation.

MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia

J. Esteve, L. Escoda, M. Tormo, 2014, Leukemia.

Immunophenotype of acute myeloid leukemia with NPM mutations: prognostic impact of the leukemic compartment size.

J. Esteve, N. Villamor, M. Tormo, 2011, Leukemia research.

Translocation (3;21) in a patient with secondary hematological malignancy.

S. Brunet, E. Molto, A. Aventín, 1990, Cancer genetics and cytogenetics.

Philadelphia-positive chronic myeloid leukemia with translocation t(3;21)

S. Brunet, A. Aventín, I. Zuazu, 1988, Cancer genetics and cytogenetics.

High‐dose chemotherapy and immunotherapy in adult Burkitt lymphoma

J. Esteve, L. Escoda, J. Hernández-Rivas, 2008, Cancer.

High-dose ifosfamide and etoposide infusion plus methylprednisolone for refractory or relapsed aggressive non-Hodgkin's lymphoma.

A. Salar, S. Brunet, R. Martino, 2000, Haematologica.

Mini-ICE regimen as mobilization therapy for chronic myelogenous leukaemia patients at diagnosis

A. Grañena, A. Aventín, S. Brunet, 1999, Bone Marrow Transplantation.

Does reduced-intensity allogeneic transplantation confer a survival advantage to patients with poor prognosis chronic lymphocytic leukaemia? A case-control retrospective analysis.

J. Briones, J. Delgado, J. Sierra, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Dose‐intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status

J. Esteve, M. Tormo, J. Hernández-Rivas, 2013, Cancer.

Post-transplant Burkit t's Leukemia or Lymphoma. Study of Five Cases Treated with Specific Intensive Therapy (PETHEMA ALL-3/97 Trial)

J. Esteve, M. Sanz, S. Brunet, 2003, Leukemia & lymphoma.

transplantation from HLA-identical sibling donors CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell

C. Solano, S. Brunet, J. Ribera, 2013 .

CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors.

Marcos González, C. Solano, S. Brunet, 2007, Blood.

Specific Intensive Chemotherapy Plus Rituximab for Advanced Burkitt’s Lymphoma or Leukemia in HIV-Positive and Negative Adult Patients.

J. Esteve, L. Escoda, A. Oriol, 2007 .

Allogeneic bone marrow transplantation for advanced Waldenstrom’s macroglobulinemia

S. Brunet, R. Martino, P. Romero, 1999, Bone Marrow Transplantation.

Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: 17 cases. Report from the EBMTG.

A. Gratwohl, S. Brunet, N. Milpied, 1991, Bone marrow transplantation.

Response to erythropoietic‐stimulating agents in patients with chronic myelomonocytic leukemia

M. Ardanaz, U. Germing, S. Brunet, 2016, European journal of haematology.

Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic Syndromes

S. Brunet, J. Bargay, J. Ribera, 2014, Leukemia & lymphoma.

Comparison of CHOP treatment with specific short-intensive chemotherapy in AIDS-related Burkitt's lymphoma or leukemia.

J. Esteve, A. Oriol, S. Brunet, 2011, Medicina clinica.

Activation of the NF‐κB signalling pathway in diffuse large B‐cell lymphoma: clinical implications

J. Briones, J. Prat, S. Brunet, 2008, Histopathology.

Results of the PETHEMA ALL‐96 trial in elderly patients with Philadelphia chromosome‐negative acute lymphoblastic leukemia

J. Sancho, M. Tormo, J. Hernández-Rivas, 2006, European journal of haematology.

Pulmonary function testing prior to reduced intensity conditioning allogeneic stem cell transplantation in an unselected patient cohort predicts posttransplantation pulmonary complications and outcome

J. Briones, P. Casán, J. Sierra, 2012, American journal of hematology.

High-dose busulfan and melphalan before bone marrow transplantation for acute nonlymphoblastic leukemia.

S. Brunet, R. Martino, I. Badell, 1995, Bone marrow transplantation.

Hematopoietic transplantation from adult unrelated donors as treatment for acute myeloid leukemia

S. Brunet, R. Martino, D. Valcárcel, 2008, Bone Marrow Transplantation.

Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patients

A. Verdeguer, S. Brunet, J. Díez, 2004, Bone Marrow Transplantation.

Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease.

J. Briones, J. Sierra, S. Brunet, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A celecoxib derivative inhibits focal adhesion signaling and induces caspase‐8‐dependent apoptosis in human acute myeloid leukemia cells

J. Sierra, R. Mangues, A. Lasa, 2008, International journal of cancer.

Microsatellite instability is not an uncommon finding in adult de novo acute myeloid leukemia

A. Aventín, J. Sierra, A. Lasa, 2005, Annals of Hematology.

High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias

A. Aventín, J. Sierra, Elena Serrano, 2008, Annals of Hematology.

Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategy.

J. Esteve, E. Montserrat, A. Grañena, 2004, Haematologica.

Treatment of Philadelphia Chromosome (Ph)-Positive Acute Lymphoblastic Leukemia (ALL) with Concurrent Chemotherapy and Imatinib Mesylate.

J. Esteve, M. Tormo, Marcos González, 2004 .

Complex measurements may be required to establish the prognostic impact of immunophenotypic markers in AML.

J. Esteve, M. Tormo, A. Órfão, 2015, American journal of clinical pathology.

The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia

J. Esteve, L. Escoda, M. Tormo, 2015, Blood Cancer Journal.

Prevention of hypermenorrhea with leuprolide in premenopausal women undergoing bone marrow transplantation

S. Brunet, R. Ghalie, E. Capdevila, 1993, American journal of hematology.

Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol.

S. Brunet, R. Martino, A. Sureda, 1999, Haematologica.

Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.

J. Briones, J. Delgado, J. Sierra, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Mobilization of peripheral blood progenitor cells by cyclophosphamide and rhGM-CSF in multiple myeloma.

J. A. Sánchez, S. Brunet, J. García, 1996, Bone marrow transplantation.

Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow Transplantation.

E. Montserrat, A. Grañena, J. Sierra, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.

J. Esteve, M. Tormo, Marcos González, 2008, Blood.

Spontaneous splenic rupture as the initial manifestation of acute lymphoblastic leukaemia: Immunophenotype and cytogenetics

A. Domingo, S. Brunet, C. Martínez, 1994, Annals of Hematology.

Prognostic Value of Monosomal Karyotype in Patients with Primary Acute Myeloid Leukemia On Behalf of Spanish CETLAM Group.

J. Esteve, I. Marugán, F. Solé, 2009 .

Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry

M. Tormo, S. Brunet, J. Bargay, 2015, Leukemia.

CD56 expression could be associated with monocytic differentiation in acute myeloid leukemia with t(8;21).

N. Villamor, M. Tormo, J. Sierra, 2001, Haematologica.

Impact of Cyclosporine Levels on the Development of Acute Graft versus Host Disease after Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

J. Briones, J. Sierra, S. Brunet, 2014, Mediators of inflammation.

Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.

L. Arenillas, M. Tormo, A. Jerez, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies

A. Ganser, F. Lo‐Coco, E. Vellenga, 2015, Annals of Hematology.

Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis

J. Esteve, M. Tormo, M. Sanz, 2009, Haematologica.

Lack of negative impact of Philadelphia chromosome in older patients with acute lymphoblastic leukaemia in the thyrosine kinase inhibitor era: comparison of two prospective parallel protocols

M. Tormo, A. Oriol, S. Brunet, 2012, British journal of haematology.

Effectiveness and safety of different azacitidine dosage regimens in patients with myelodysplastic syndromes or acute myeloid leukemia.

M. Tormo, S. Brunet, J. Bargay, 2014, Leukemia research.

[Enzyme immunoassay using recombinant env peptides of human immunodeficiency virus type 1 (HIV-1) as a confirmatory technic for anti-HIV-1].

S. Brunet, I. Zuazu, J. Fornells, 1989 .

Acute rhabdomyolysis and myonecrosis complicating aeromonas bacteremia in neutropenic patients with hematologic malignancies: report of two cases.

S. Brunet, R. Martino, A. Santamaría, 1997, Haematologica.

Acute rhabdomyolysis complicating viridans streptococcal shock syndrome.

S. Brunet, R. Martino, A. Sureda, 1994, Acta haematologica.

Do Patients and Physicians Agree When They Assess Quality of Life?

J. Briones, A. Barata, S. Brunet, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

MEIS 1 expression is downregulated through promoter hypermethylation in AML1-ETO acute myeloid leukemias

A. Lasa, M. Carnicer, S. Brunet, 2004, Leukemia.

Viridans streptococcal bacteremia and viridans streptococcal shock syndrome in neutropenic patients: comparison between children and adults receiving chemotherapy or undergoing bone marrow transplantation.

S. Brunet, R. Martino, R. Manteiga, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Non-secretory lambda multiple myeloma.

S. Brunet, C. Guarner, J. Soler, 1989, Journal of clinical pathology.

Updated experience with inolimomab as treatment for corticosteroid-refractory acute graft-versus-host disease.

J. Briones, J. Sierra, S. Brunet, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

K313dup is a recurrent CEBPA mutation in de novo acute myeloid leukemia (AML)

A. Aventín, J. Sierra, Elena Serrano, 2008, Annals of Hematology.

Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia.

J. Esteve, E. Montserrat, M. Tormo, 2006, Blood.

Listeriosis in Bone Marrow Transplant Recipients

S. Brunet, R. Martino, I. Badell, 1996 .

NEDD9, an independent good prognostic factor in intermediate-risk acute myeloid leukemia patients

M. González-Díaz, J. Sierra, R. Mangues, 2017, Oncotarget.

Focal Adhesion Genes Refine the Intermediate-Risk Cytogenetic Classification of Acute Myeloid Leukemia

M. González-Díaz, J. Sierra, R. Mangues, 2018, Cancers.

NEDD9, an independent good prognostic factor in intermediate-risk acute myeloid leukemia patients

M. González-Díaz, J. Sierra, R. Mangues, 2017, Oncotarget.